Halozyme Therapeutics (HALO) Return on Sales [ROS] (2010 - 2026)
Halozyme Therapeutics (HALO) posted Return on Sales [ROS] of 59.80% for Q2 2026, down 2.35 percentage points from 62.15% a year earlier but up 10.82 percentage points from the prior quarter.
Halozyme Therapeutics (HALO) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Halozyme Therapeutics was 35.90%, down 22.02 percentage points year-over-year; for FY2025, it came in at 33.58%, down 20.73 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of -20.33 percentage points (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Return on Sales [ROS] was 54.32% in FY2024 (+13.61 pp), 40.71% in FY2023 (+0.18 pp), 40.53% in FY2022 (-21.71 pp) and 62.24% in FY2021 (+8.33 pp).
- Quarterly Return on Sales [ROS] has run from a low of -20.56% in Q4 2025 to a high of 65.26% in Q3 2021 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last three quarters, with an average year-over-year change of -4.31 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2023, with a gain of 20.38 percentage points; the weakest was Q4 2025, with a drop of 79.45 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 48.98% (Q1 2026), -20.56% (Q4 2025) and 61.51% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | 59.80% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.80% |
| Mar 31, 2026 | 48.98% |
| Dec 31, 2025 | -20.56% |
| Sep 30, 2025 | 61.51% |
| Jun 30, 2025 | 62.15% |
| Mar 31, 2025 | 53.44% |
| Dec 31, 2024 | 58.89% |
| Sep 30, 2024 | 56.26% |
| Jun 30, 2024 | 50.67% |
| Mar 31, 2024 | 48.78% |
| Dec 31, 2023 | 43.92% |
| Sep 30, 2023 | 40.86% |
| Jun 30, 2023 | 42.73% |
| Mar 31, 2023 | 33.18% |
| Dec 31, 2022 | 41.05% |
| Sep 30, 2022 | 39.86% |
| Jun 30, 2022 | 22.35% |
| Mar 31, 2022 | 64.52% |
| Dec 31, 2021 | 55.42% |
| Sep 30, 2021 | 65.26% |
Halozyme Therapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();